Xiangcai Co

Xiangcai Co Net Debt/Equity

The Net Debt to Equity Ratio of Xiangcai Co (600095.SS) as of Nov 18, 2026 is 0.77. In the previous year, Net Debt to Equity Ratio was -0.84 — a change of -191.73% (higher).

Net Debt/Equity

0.77

YoY

-191.73%

Last updated:

Net Debt to Equity Ratio of Xiangcai Co is 2025 0.77 . Net Debt to Equity Ratio of Xiangcai Co was 2024 -0.84 . It decreases by -191.73% higher compared to the previous year.

The Xiangcai Co Net Debt/Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt/Equity
Date
Net Debt/Equity
Jan 1, 2018
-0.00 CNY
Jan 1, 2019
0.08 CNY
Jan 1, 2020
-1.58 CNY
Jan 1, 2021
-0.94 CNY
Jan 1, 2022
-0.70 CNY
Jan 1, 2023
-0.80 CNY
Jan 1, 2024
-0.84 CNY
Jan 1, 2025
0.77 CNY
The Xiangcai Co Net Debt/Equity history
YEARNet Debt/EquityYoY
0.77-191.73%
-0.84+4.48%
-0.80+14.78%
-0.70-25.37%
-0.94-40.73%
-1.58-2,188.73%
0.08-1,770.63%
-0.00-91.61%
-0.05-72.01%
-0.19+394.45%
-0.04-117.50%
0.22—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Xiangcai Co Stock analysis

What does Xiangcai Co do? Xiangcai Co., Ltd. generates revenue through multiple business segments including non-GMO soybean products processing, pharmaceuticals, waterproof membrane manufacturing, and industrial plants. The company produces soybean protein isolate, soybean tissue protein, and soybean nutritious food under its soybean deep processing division. Its pharmaceutical segment focuses on thymopeptide enteric-coated tablets and other immune system treatment drugs. The waterproof membrane business manufactures and sells polyethylene polypropylene fiber coils, load-bearing coils, and joint profiles. Real estate development and property management contribute to the company's revenue through residential and industrial real estate projects. The primary buyers for soybean deep processing products include food manufacturers and health supplement companies seeking non-GMO ingredients. Pharmaceutical customers consist of hospitals, pharmacies, and healthcare providers purchasing thymopeptide enteric-coated tablets for immune system treatments. Waterproof membrane products are sold to construction companies and building contractors for infrastructure and residential projects. Real estate clients are residential buyers and industrial tenants requiring property development and management services. Xiangcai Co., Ltd. serves distinct market segments: food and beverage manufacturers for soybean products, healthcare institutions for pharmaceuticals, construction firms for waterproofing solutions, and residential/industrial property occupants for real estate services. The company's product portfolio spans from raw material processing to end-user applications across these sectors, creating diversified revenue streams. Xiangcai Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Xiangcai Co stock

Net Debt to Equity Ratio of Xiangcai Co is 0.77 in 2025.

Net Debt to Equity Ratio of Xiangcai Co changed from -0.84 to 0.77, representing a -191.73% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to Equity Ratio Xiangcai Co since 2006 – with annual values, charts, and detailed analysis.

Net Debt/Equity adjusts the debt-to-equity ratio by subtracting cash from total debt. It provides a more accurate picture of actual leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to Equity Ratio's Xiangcai Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Xiangcai Co

All Key Metrics — Xiangcai Co